Browsing by Author Cooper, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2012Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholdsChalmers, John; Colagiuri, Stephen; Fulcher, Greg; Neal, Bruce; Patel, Anushka; Woodward, Mark; Cooper, M; de Galan, B; Hamet, Pavel; Harrap, Stephen B.; Heller, Simon; Li, Q; MacMahon, Stephen; Marre, Michel; Ninomiya, T; Poulter, Neil; Travert, F; Zoungas, Sophia; The George Institute for Global Health; Central Clinical School: Medicine; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthAssociation of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds, Diabetologia: clinical and experimental diabetes and metabolism, vol.55, 3, 2012,pp 636-643
2017Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetesChalmers, John; Colagiuri, Stephen; Mohammedi, Kamel; Woodward, Mark; Zoungas, Sophia; Cooper, M; Harrap, Stephen B.; Mancia, Giuseppe; Marre, Michel; Poulter, Neil; Williams, Bryan; The George Institute for Global Health; Boden Institute; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthComparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes, Cardiovascular Diabetology, vol.16, 1, 2017,pp 1-9
2017Position statement on radiopharmaceutical production for clinical trialsKumar, Vijay; Bormans, Guy; Buck, A; Chiti, A; Cooper, M; Croasdale, J; Desruet, M; Liu, Y; Penuelas, I; Rossetti, C; Schiavo, R; Schwarz, S W; Windhorst, Albert D.; Childrens Hospital Westmead: Paediatrics & Child HealthPosition statement on radiopharmaceutical production for clinical trials, EJNMMI Radiopharmacy and Chemistry, vol.2, 1, 2017,pp 1-3